Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel solid-phase synthesis of Teixobactin analogs via copper-mediated cyclization. Reduces steps and cost for antibiotic manufacturing.
Patent CN105693748A details a high-yield 7-ACCA synthesis route. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103044397A reveals a cost-effective besifloxacin synthesis using 2,4,5-trifluorobenzoic acid, offering high yields and simplified purification for pharmaceutical supply chains.
Patent CN104086550B details a high-pressure synthetic route for Tetramethyluric Acid. This method offers scalable production and high purity for pharmaceutical supply chains.
Patent CN108484499A reveals a green rhodium-catalyzed route for isoquinoline derivatives, offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Novel synthesis route for Alvimopan intermediates via CN102127005A. Offers high purity, chiral control, and cost-effective API manufacturing solutions.
Advanced synthesis of alpha-isopropyl-3,4-dimethoxyphenylacetonitrile via patent CN113444020B. High-yield route for Verapamil intermediates with reduced toxicity and cost.
Patent CN108484499A reveals green rhodium catalyzed synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity and supply reliability.
Novel salt formation method ensures over 99 percent purity for Perampanel intermediate. Reduces impurities significantly for reliable pharmaceutical intermediate supply chains.
Patent CN104560905B reveals green enzymatic route for chiral sulfoxides. Enables cost reduction and sustainable supply chain for pharmaceutical intermediates manufacturing globally.
Novel condensing agent process for Zafirlukast reduces impurities and cost. Reliable supply chain for asthma medication intermediates with scalable production.
Patent CN111620793B details a copper-catalyzed asymmetric trifluoromethyl cyanation method offering high enantioselectivity and mild conditions for reliable pharmaceutical intermediate manufacturing.
Patent CN1514836A reveals a novel one-pot method for oxabispiperidine besylates, eliminating anion exchange steps for cost-effective pharmaceutical intermediate manufacturing.
Novel CDC25B inhibitor synthesis via microwave or base catalysis. High yield, scalable process for anti-tumor drug development and reliable supply chain.
Patent CN102311381A details a high-purity Heck coupling method for Acrivastine precursors, offering superior selectivity and simplified purification for pharmaceutical manufacturing.
Patent CN102775384B details novel iminosugar synthesis offering high-purity glycosidase inhibitors with streamlined commercial scale-up potential for global supply chains.
Efficient synthesis of daclatasvir starting material via patent CN107814789B. Low-cost route ensures supply chain stability for global API manufacturers.
Patent CN104169256B reveals efficient Pd-catalyzed route for Etoricoxib intermediate, offering supply chain stability and cost reduction for pharmaceutical manufacturing.
Novel odorless synthesis of L-erythro-biopterin via long-chain thiols. Reduces cost and improves supply chain reliability for API manufacturing.
Patent CN103936727A details a novel purification method reducing alpha-impurities. This ensures supply chain reliability and cost efficiency for pharmaceutical intermediates.